{"id":1628,"date":"2026-03-18T17:30:56","date_gmt":"2026-03-18T17:30:56","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/03\/18\/trial-of-novel-autoimmune-disease-treatment-icp-538-launches-in-china\/"},"modified":"2026-03-18T17:30:56","modified_gmt":"2026-03-18T17:30:56","slug":"trial-of-novel-autoimmune-disease-treatment-icp-538-launches-in-china","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/03\/18\/trial-of-novel-autoimmune-disease-treatment-icp-538-launches-in-china\/","title":{"rendered":"Trial of novel autoimmune disease treatment ICP-538 launches in China"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/03\/18\/trial-testing-autoimmune-disease-treatment-icp-538-ms-launches-china\/\" title=\"Trial of novel autoimmune disease treatment ICP-538 launches in China\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"422\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/03\/patient-doctor-800x422.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A doctor holds out a tablet for a patient to see while reviewing medical records in an exam room.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"160500\" \/><\/a><\/p>\n<p>Innocare Pharma has dosed the first healthy volunteer in a clinical trial in China testing ICP-538, its oral treatment candidate for multiple sclerosis (MS) and other autoimmune diseases. The novel experimental therapy works by promoting the degradation of the VAV1 protein, essential for the function of T-cells and B-cells, which are immune cells that play [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/03\/18\/trial-testing-autoimmune-disease-treatment-icp-538-ms-launches-china\/\">Trial of novel autoimmune disease treatment ICP-538 launches in China<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/03\/18\/trial-testing-autoimmune-disease-treatment-icp-538-ms-launches-china\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Innocare Pharma has dosed the first healthy volunteer in a clinical trial in China testing ICP-538, its oral treatment candidate for multiple sclerosis (MS) and other autoimmune diseases. The novel experimental therapy works by promoting the degradation of the VAV1 protein, essential for the function of T-cells and B-cells, which are immune cells that play&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1629,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1628","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1628"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1628\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1629"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}